AU2003268353A1 - Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection - Google Patents
Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infectionInfo
- Publication number
- AU2003268353A1 AU2003268353A1 AU2003268353A AU2003268353A AU2003268353A1 AU 2003268353 A1 AU2003268353 A1 AU 2003268353A1 AU 2003268353 A AU2003268353 A AU 2003268353A AU 2003268353 A AU2003268353 A AU 2003268353A AU 2003268353 A1 AU2003268353 A1 AU 2003268353A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- prevention
- treatment
- streptococcus pneumoniae
- active infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000193998 Streptococcus pneumoniae Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40708202P | 2002-08-30 | 2002-08-30 | |
| US60/407,082 | 2002-08-30 | ||
| PCT/US2003/027401 WO2004020609A2 (en) | 2002-08-30 | 2003-09-02 | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003268353A8 AU2003268353A8 (en) | 2004-03-19 |
| AU2003268353A1 true AU2003268353A1 (en) | 2004-03-19 |
Family
ID=31978415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003268353A Abandoned AU2003268353A1 (en) | 2002-08-30 | 2003-09-02 | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003268353A1 (en) |
| WO (1) | WO2004020609A2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0407384A (en) | 2003-02-14 | 2006-02-21 | Pfizer Prod Inc | pyridines-triazoles as anti-inflammatory compounds |
| WO2006048757A2 (en) * | 2004-11-05 | 2006-05-11 | Pharmacia & Upjohn Company Llc | Anti-bacterial vaccine compositions |
| WO2006048753A2 (en) * | 2004-11-05 | 2006-05-11 | Pharmacia & Upjohn Company Llc | Anti-bacterial vaccine compositions |
| US8722055B2 (en) * | 2006-09-27 | 2014-05-13 | St. Jude Children's Research Hospital | Synthetic Streptococcus pneumoniae vaccine |
| GB0714963D0 (en) * | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| JP5697991B2 (en) | 2008-02-01 | 2015-04-08 | サノフィ パストゥール リミテッドSanofi Pasteur Limited | Diagnostic assays |
| MX2012000158A (en) | 2009-06-29 | 2012-06-08 | Genocea Biosciences Inc | Vaccines and compositions against streptococcus pneumoniae. |
| AU2011336366B2 (en) | 2010-12-03 | 2016-05-12 | Sanofi Pasteur Limited | Composition for immunization against Streptococcus pneumoniae |
| AU2012207088A1 (en) | 2011-01-20 | 2013-05-02 | Children's Medical Center Corporation | Vaccines and compositions against Streptococcus pneumoniae |
| EP2817320A1 (en) * | 2012-02-24 | 2014-12-31 | Novartis AG | Pilus proteins and compositions |
| WO2017091707A1 (en) * | 2015-11-25 | 2017-06-01 | Wake Forest University Health Sciences | Pneumococcal inhibitory factor compositions and methods of use thereof |
| CA3111459A1 (en) * | 2018-09-12 | 2020-03-19 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6420135B1 (en) * | 1996-10-31 | 2002-07-16 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
-
2003
- 2003-09-02 AU AU2003268353A patent/AU2003268353A1/en not_active Abandoned
- 2003-09-02 WO PCT/US2003/027401 patent/WO2004020609A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004020609A9 (en) | 2004-05-13 |
| AU2003268353A8 (en) | 2004-03-19 |
| WO2004020609A3 (en) | 2004-07-15 |
| WO2004020609A2 (en) | 2004-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001280702A1 (en) | Compounds and methods for treatment and diagnosis of chlamydial infection | |
| AU2002255248A1 (en) | Diagnosis, treatment and research of mental disorders | |
| HK1049656A1 (en) | Fab i inhibitors | |
| WO2003088897A3 (en) | Fab i inhibitors | |
| AU2003901008A0 (en) | Composition for the treatment and prevention of bacterial infections | |
| ZA200108215B (en) | Compositions and methods for treatment of staphylococcal infection. | |
| AU2003268353A1 (en) | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection | |
| AU2002356868A1 (en) | Methods for the prevention or treatment of bacterial and fungal infections | |
| AU2000255628A1 (en) | Formulation comprising thymol useful in the treatment of drug resistant bacterial infections | |
| WO2000058475A3 (en) | Streptococcus pneumoniae antigens | |
| AU2002239485A1 (en) | Methods for improved diagnosis and treatment of mycobacterial infections | |
| WO2003009859A1 (en) | Immunotherapy for humans | |
| AU2001259507A1 (en) | Compounds and methods for the diagnosis and treatment of ehrlichia infection | |
| AU2003261782A1 (en) | Bacteriophages and remedies for bacterial infection | |
| AU2003210266A1 (en) | Treatment, diagnosis and imaging of disease | |
| AU2003247841A1 (en) | Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes | |
| AU4204700A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection | |
| AU4654500A (en) | Prevention, diagnosis and treatment of lyme disease | |
| AU2002330724A1 (en) | Diagnosis, prevention and treatment of cancer | |
| AU2002249891A1 (en) | Compounds and methods for the diagnosis and treatment of babesia infection | |
| WO2003065979A3 (en) | Methods of diagnosis, monitoring and treatment of fertility | |
| AU2001292943A1 (en) | Prevention and treatment of streptococcal and staphylococcal infection | |
| AU2001267177A1 (en) | Diagnosis and treatment of herpes infections | |
| AU2002367861A1 (en) | Prevention and treatment of streptococcal and staphylococcal infection | |
| ZA200108013B (en) | Monthly closes for treatment of Streptococcus pneumoniae infections. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |